Track topics on Twitter Track topics that are important to you
EU5 Biopsy Procedures Outlook to 2023
GlobalData's new report, "EU5 Biopsy Procedures Outlook to 2023", provides key procedures data on the EU5 Biopsy Procedures. The report provides procedure volumes within market segments Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most uptodate data of the industry possible.
The epidemiologybased forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiologybased forecasting model arrives at the final numbers.
Extensive interviews are conducted with key opinion leaders KOLs, physicians and industry experts to validate the procedure volumes.
EU5 Biopsy Procedures volumes by segments Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures.
Projections for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
Reasons to buy
Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
Develop marketentry and market expansion strategies.
Track and monitor developments in breast cancer research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...